S&P down YTD — winners hiding
The S&P 500 is down about 3% year‑to‑date, but three stocks—SNDK (tech), TPL (energy/land) and MRNA (healthcare)—are the index’s top performers and have materially outpaced the market so far in 2026 S&P YTD & top performers. Analysts warn volatility is high beneath that headline decline — and income investors are eyeing names like Campbell’s for yield even as it teeters near S&P 500 removal discussions volatility note Campbell’s dividend risk.
The S&P 500 has returned −3.6% year‑to‑date through March 12, 2026. (statmuse.com) Bucking the index, Sandisk (SNDK) is up roughly 160% YTD and reported fiscal Q2 2026 non‑GAAP EPS of $6.20 on $3.03 billion revenue in a Jan. 29 earnings release that called out a datacenter/AI demand surge. (slickcharts.com) Texas Pacific Land (TPL) has risen about 84% YTD while sitting on roughly 882,000 surface acres in the Permian Basin, and the company reported Q4 2025 total revenue of $211.6 million and a 12.5% dividend increase in its Feb. 18 release. (slickcharts.com) Moderna (MRNA) is up around 81% YTD amid pipeline optimism and corporate moves: the company announced a settlement that will require a $950 million upfront payment (potentially rising to $2.25 billion) and reiterated targets for up to 10% revenue growth in 2026. (slickcharts.com) Beneath the headline index drop, market breadth and volatility are extreme — Bespoke counted 57 S&P names up ≥20% and 47 down ≥20%, and the CBOE VIX spiked to about 25.07 on March 11, 2026. (axios.com) Income names are under pressure: Campbell’s reported weaker Q2 fiscal 2026 results on March 11 and trimmed full‑year guidance while keeping a $0.39 quarterly dividend, leaving analysts to flag a payout ratio and liquidity stress as the stock tests multi‑year lows. (thecampbellscompany.com)
